These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8856147)

  • 1. In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors.
    Hanson WL; McCullough RG; Selig WM; Wieczorek M; Ross S; Whalley ET; Stewart JM; Gera L
    Immunopharmacology; 1996 Jun; 33(1-3):191-3. PubMed ID: 8856147
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.
    Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L
    Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new generation of bradykinin antagonists.
    Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of potent bradykinin antagonist dimers.
    Gera L; Stewart JM; Whalley E; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):178-82. PubMed ID: 8856144
    [No Abstract]   [Full Text] [Related]  

  • 5. A new class of bradykinin antagonists containing indanylglycine.
    Gera L; Stewart JM
    Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
    [No Abstract]   [Full Text] [Related]  

  • 6. Potent, long-acting bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New bradykinin antagonists having very high potency at B1 receptors.
    Gera L; Stewart JM; Whalley ET; Burkard M; Zuzack JS
    Immunopharmacology; 1996 Jun; 33(1-3):183-5. PubMed ID: 8856145
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
    Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D
    Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of bradykinin B2-receptors on endothelial cells induces relaxation and contraction in porcine basilar artery in vitro.
    Miyamoto A; Ishiguro S; Nishio A
    Br J Pharmacol; 1999 Sep; 128(1):241-7. PubMed ID: 10498858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonists for kinin B1 and B2 receptors in the mouse.
    Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK; Dawson LG; Hall JM
    Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Immunopharmacology; 1997 Jun; 36(2-3):167-72. PubMed ID: 9228542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-selectivity of new bradykinin antagonists for B1 receptors.
    Rhaleb NE; Gobeil F; Regoli D
    Life Sci; 1992; 51(11):PL125-9. PubMed ID: 1326066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two B1 and B2 bradykinin receptor antagonists fail to inhibit the Ca2+ response elicited by bradykinin in human skin fibroblasts.
    Cassano G; Susca F; Lippe C; Guanti G
    Gen Pharmacol; 1999 Feb; 32(2):239-44. PubMed ID: 10188626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs.
    Nakhostine N; Ribuot C; Lamontagne D; Nadeau R; Couture R
    Br J Pharmacol; 1993 Sep; 110(1):71-6. PubMed ID: 8220916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for kinins: from classical pharmacology to molecular biology.
    Regoli D; Pheng LH; Allogho SN; Nguyen-Le XK; Gobeil F
    Immunopharmacology; 1996 Jun; 33(1-3):116-22. PubMed ID: 8856128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin-induced vascular responses in dog isolated lingual artery.
    Tsukada M; Chiba S
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):456-60. PubMed ID: 10386238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of des-Arg9-bradykinin-induced contraction in guinea-pig gallbladder in vitro.
    Cabrini DA; Calixto JB
    Eur J Pharmacol; 1997 Jul; 331(1):31-8. PubMed ID: 9274927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.
    Inamura N; Asano M; Hatori C; Sawai H; Hirosumi J; Fujiwara T; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Oku T; Nakahara K
    Eur J Pharmacol; 1997 Aug; 333(1):79-86. PubMed ID: 9311664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.